Jan Versijpt

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Nicolas Vandenbussche

King’s College London

UNITED KINGDOM

View details

Guy Nagels

Vrije Universiteit Brussel

BELGIUM

View details

Jean Schoenen

Honorary Professor

University of Liege

BELGIUM

View details

Stijn Denissen

Vrije Universiteit Brussel

BELGIUM

View details

Margarita Sanchez Del Rio

Headache specialist

Clinica Universidad de Navarra

SPAIN

View details

Messoud Ashina

Professor

DENMARK

View details

Faisal Mohammad Amin

Associate Professor

University of Copenhagen

DENMARK

View details

Anne-Marie Vanbinst

Vrije Universiteit Brussel

BELGIUM

View details

Olujide Oyeniran

Lawson Research Institute at St. Joseph's

CANADA

View details

Zaza Katsarava

APL Professor

Universität Duisburg-Essen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jan Versijpt

Research Interests

Explore related searches

Contact this professor

Articles (19)

Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives

Impact of CGRP monoclonal antibody treatment on blood pressure in patients with migraine

Oxygen as an abortive therapy in cluster headache: a narrative review and clinical practice aspects

Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial

Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4

Burden of migraine in patients attending Belgian headache specialists

The comparative effectiveness of migraine preventive drugs

Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

Imaging blood-brain barrier dysfunction

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2

Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update

A qualitative study with people with young-onset dementia and their family caregivers on advance care planning

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs

CSF and Blood Neurofilament Levels in Athletes Participating in Physical Contact Sports

Collaborators (10)

Nicolas Vandenbussche

Guy Nagels

Jean Schoenen

Stijn Denissen

Margarita Sanchez Del Rio

Messoud Ashina

Faisal Mohammad Amin

Anne-Marie Vanbinst

Olujide Oyeniran

Zaza Katsarava

Make your next move.